Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125722721 | 12572272 | 1 | I | 2008 | 20160711 | 20160719 | 20160719 | EXP | US-ASTRAZENECA-2016SE75367 | ASTRAZENECA | 54.00 | YR | F | Y | 49.90000 | KG | 20160719 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125722721 | 12572272 | 1 | PS | ZOMIG | ZOLMITRIPTAN | 1 | Oral | 1.0DF UNKNOWN | 21231 | 1 | DF | TABLET | |||||||
| 125722721 | 12572272 | 2 | SS | ZOMIG | ZOLMITRIPTAN | 1 | Oral | 5 MG, OCCASION REQUIRED 2. UNKNOWN | 21231 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125722721 | 12572272 | 1 | Migraine |
| 125722721 | 12572272 | 2 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125722721 | 12572272 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125722721 | 12572272 | Body height decreased | |
| 125722721 | 12572272 | Osteoporosis | |
| 125722721 | 12572272 | Systemic lupus erythematosus | |
| 125722721 | 12572272 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125722721 | 12572272 | 1 | 1997 | 0 |